APIS Assay Technologies Company

Introducing APIS Assay Technologies APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility.

Headquarters: Manchester, Manchester, United Kingdom
Total Funding: £23 000 000
Founded Date: 2018
Industry: Diagnostics
Employee Number: 11-50
Estimated Revenue: £780 000 - £7 800 000